Tumor targeting with radiolabeled αvβ3 integrin binding peptides in a nude mouse model

Cancer Research

Volumn 62, Issue 21, 2002, Pages 6146-6151

  Janssen, Marcel L ^a   Oyen, Wim J ^a   Dijkgraaf, Ingrid ^a   Massuger, Leon F ^a   Frielink, Cathelijne ^a   Edwards, D Scott ^b   Rajopadhye, Milind ^b   Boonstra, Henk ^a   Corstens, Frans H ^a   Boerman, Otto C ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; ALPHA5 INTEGRIN; ARGINYLGLYCYLASPARTIC ACID; BETA3 INTEGRIN; INDIUM; RADIOISOTOPE; SCLEROPROTEIN; YTTRIUM 90;

AMINO ACID SEQUENCE; ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CELL PROLIFERATION; CONTROLLED STUDY; ISOTOPE LABELING; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL; SCINTISCANNING; TUMOR GROWTH; TUMOR XENOGRAFT;

ANIMALS; FEMALE; HUMANS; INDIUM RADIOISOTOPES; INTEGRIN ALPHAVBETA3; MICE; MICE, INBRED BALB C; MICE, NUDE; OLIGOPEPTIDES; OVARIAN NEOPLASMS; RADIOPHARMACEUTICALS; SUBSTRATE SPECIFICITY; TECHNETIUM; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS; YTTRIUM RADIOISOTOPES;

EID: 0036829759     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ruoslahti, E., and Pierschbacher, M. D. New perspectives in cell adhesion: RGD and integrins. Science (Wash. DC), 238: 491-497, 1987.
2. Plow, E. F., Haas, T. A., Zhang, L., Loftus, J., and Smith, J. W. Ligand binding to integrins. J. Biol. Chem., 275: 21785-21788, 2000.
3. Liekens, S., De Clercq, E., and Neyts, J. Angiogenesis: Regulators and clinical applications. Biochem. Pharmacol., 61: 253-270, 2001.
4. 3 blocks human breast cancer growth and angiogenesis in human skin. J. Clin. Investig., 96: 1815-1822, 1995.
5. Brooks, P. C., Clark, R. A., and Cheresh, D. A. Requirement of vascular integrin α(v)β(3) for angiogenesis. Science (Wash. DC), 264: 569-571, 1994.
6. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell, 79: 1157-1164, 1994.
7. 3 integrin in human melanoma cells. Eur. J. Cancer, 36: 410-422, 2000.
8. Boerman, O. C., Oyen, W. J., and Corstens, F. H. Radio-labeled receptor-binding peptides: A new class of radiopharmaceuticals. Semin. Nucl. Med., 30: 195-208, 2000.
9. 90Y-labeled DTPA-biomolecule conjugates. Bioconjug. Chem., 12: 84-91, 2001.
10. Haubner, R., Wester, H. J., Burkhart, F., Senekowitsch-Schmidtke, R., Weber, W., Goodman, S. L., Kessler, H., and Schwaiger, M. Glycosylated RGD-containing peptides: Tracer for tumor targeting and angiogenesis imaging with improved biokinetics. J. Nucl. Med., 42: 326-336, 2001.
11. Van Hagen, P. M., Breeman, W. A., Bernard, H. F., Schaar, M., Mooij, C. M., Srinivasan, A., Schmidt, M. A., Krenning, E. P., and de Jong, M. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy. Int. J. Cancer, 90: 186-198, 2000.
12. Sivolapenko, G. B., Skarlos, D., Pectasides, D., Stathopoulou, E., Milonakis, A., Sirmalis, G., Stuttle, A., Courtenay Luck, N. S., Konstantinides, K., and Epenetos, A. A. Imaging of metastatic melanoma utilising a technetium-99m labelled RGD-containing synthetic peptide. Eur. J. Nucl. Med., 25: 1383-1389, 1998.
13. 3 integrin antagonists: A new class of tracers for tumor targeting. J. Nucl. Med., 40: 1061-1071, 1999.
14. 18F-labeled RGD-containing glycopeptide and positron emission tomography. Cancer Res., 61: 1781-1785, 2001.
15. 111In-RP686 and efficacy in dogs. Proc. Am. Assoc. Cancer Res., 42: 94, 2001.
16. 99mTc-labeling of hydrazino nicotinamide-modified biologically active molecules using imine-N-containing heterocycles as coligands. Bioconjug. Chem., 9: 583-595, 1998.
17. 3-integrin in lung and other organs. Am. J. Physiol. Lung Cell. Mol. Physiol., 278: L217-L226, 2000.
18. 99mTc-labeled hydrazino nicotinamide derivatized polypeptides and peptides. Nucl. Med. Biol., 28: 155-164, 2001.
19. Behr, T. M., Goldenberg, D. M., and Becker, W. Reducing the renal uptake of radiolabeled antibody fragments and peptides for diagnosis and therapy: Present status, future prospects and limitations. Eur. J. Nucl. Med., 25: 201-212, 1998.
20. 3-octreotide. Eur. J. Nucl. Med., 28: 426-434, 2001.